PEGS Summit Europe - 2009³â 10¿ù 6ÀÏ¡8ÀÏ µ¶ÀÏ¿¡¼ °³ÃÖ
PEGS EuropeÀº ´Ü¹éÁú ¿£Áö´Ï¾î¸µÀÇ ¸ðµç Ãø¸éÀ» ¸Á¶óÇÑ Cambridge Healthtech Institute ÁÖÃÖ ÄÁÆÛ·±½º À̺¥Æ®ÀÔ´Ï´Ù. â¾à¿¡¼ ÀÓ»ó¿¡ À̸£±â±îÁö ´Ü¹éÁú ¹ßÇö ¹× »ý¼º, ÆäÀÌÁö µð½ºÇ÷¹ÀÌ(phage display), Ç×ü ¿£Áö´Ï¾î¸µ µîÀÇ ¹æ¹ý ¹× ±â¼ú¿¡ °üÇÑ Ãֽе¿ÇâÀ» µéÀ¸½Ç ¼ö ÀÖ½À´Ï´Ù. ¹Ì±¹¿¡¼ ÀÌ¹Ì ³ôÀº Æò°¡¸¦ ¹Þ°í ÀÖ´Â PEGS À̺¥Æ®°¡ À¯·´¿¡¼ °³Ãֵ˴ϴÙ. º» ȸÀÇ´Â Á¦3ȸ Annual Protein Expression - Europe ¹× Antibodies - Europe°ú 2°ÇÀÇ »õ·Î¿î ȸÀÇ(Antibodies from Bench to Bedside ¹× Phage Display to Develop Therapeutics)°¡ ÇÕµ¿°³Ãֵ˴ϴÙ. ¶ÇÇÑ ¹ÙÀÌ¿ÀÅ×Å©³î·¯Áö¿¡ °üÇÑ À¯·´ ÃÖ´ëÀÇ À̺¥Æ® BIOTECHNICA¿Í °°Àº ȸÀå¿¡¼ °³Ãֵ˴ϴÙ.
Keynote Speakers
Adreas Pluckthun, Ph.D., Professor of Biochemistry, University of Zurich Debbie Law, Ph.D., Chief Scientific Officer, Ablynx nv Georg Feger, Ph.D., Site Manager, Geneva Research Center, Vice President, Research Head of NBE Technologies, Merck Serono S.A.
Joerg Standfuss, Ph.D., Senior Post-Doctoral Researcher, MRC-Laboratory of Molecular Biology Pamela A. Trail, Ph.D., Vice President, Oncology, MedImmune, Inc. Trevor Wilkinson, Ph.D., Head, Protein Sciences, MedImmune Ltd
|